Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Scalp Cool Devices for Chemotherapy Induced Hair Loss Market by Type (Scalp Cool Caps, Scalp Cool Systems), By Application (Breast Cancer, Prostate Cancer, Ovarian Cancer, Ovarian Cancer, Lung Cancer, Other Solid Tumors) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Scalp Cool Devices for Chemotherapy Induced Hair Loss Market by Type (Scalp Cool Caps, Scalp Cool Systems), By Application (Breast Cancer, Prostate Cancer, Ovarian Cancer, Ovarian Cancer, Lung Cancer, Other Solid Tumors) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 211281 3300 Medical Devices & Consumables 377 235 Pages 4.5 (36)
                                          
The global scalp cool devices for chemotherapy induced hair loss market was valued at USD 2.62 billion in 2018 and is expected to reach USD 4.21 billion by 2030, growing at a CAGR of 5.3% from 2020 to 2030. The market is primarily driven by the increasing incidence of cancer, which would propel the demand for scalp cooling devices due to their efficacy in counteracting side effects such as hair loss or bladder irritation among patients undergoing chemotherapy treatment. Scalp Cool Caps accounted for the majority share of the global market in 2018 and are expected to continue dominating during the forecast period owing to their low price and easy usage process. Scalp Cool Systems are estimated to grow at a higher CAGR due to their convenience and effectiveness as well as lower cost as compared with Scalp Cool Caps; however, they still account for less share than Scalp Cool Caps due to their high purchase price which could limit its growth potential during the forecast period. Breast Cancer accounted for 60% share of total revenue in 2018 while Ovarian Cancer had 11%. North America is estimated account for 50% revenue share during 2019-2023 while Asia Pacific region will dominate with 57% revenue share by 2030 end over Latin America, Europe and Middle East & Africa region respectively. The Americas dominated the global market in 2018 and are estimated to continue dominating through 2030 with a CAGR of 5.9% from 2019-2030. North America is expected to lead the Americas region with a revenue share of 45%. Asia Pacific is likely to be fastest growing region during 2020-2030, primarily driven by China and India which account for 22% and 13% respectively.

Industry Growth Insights published a new data on “Scalp Cool Devices for Chemotherapy Induced Hair Loss Market”. The research report is titled “Scalp Cool Devices for Chemotherapy Induced Hair Loss Market research by Types (Scalp Cool Caps, Scalp Cool Systems), By Applications (Breast Cancer, Prostate Cancer, Ovarian Cancer, Ovarian Cancer, Lung Cancer, Other Solid Tumors), By Players/Companies Dignitana, Paxman, Penguin Cold Caps, Chemotherapy Cold Caps, Medline Industries”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Research Report

By Type

Scalp Cool Caps, Scalp Cool Systems

By Application

Breast Cancer, Prostate Cancer, Ovarian Cancer, Ovarian Cancer, Lung Cancer, Other Solid Tumors

By Companies

Dignitana, Paxman, Penguin Cold Caps, Chemotherapy Cold Caps, Medline Industries

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

235

Number of Tables & Figures

165

Customization Available

Yes, the report can be customized as per your need.


Global Scalp Cool Devices for Chemotherapy Induced Hair Loss Industry Outlook


Global Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Report Segments:

The global Scalp Cool Devices for Chemotherapy Induced Hair Loss market is segmented on the basis of:

Types

Scalp Cool Caps, Scalp Cool Systems

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Breast Cancer, Prostate Cancer, Ovarian Cancer, Ovarian Cancer, Lung Cancer, Other Solid Tumors

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Dignitana
  2. Paxman
  3. Penguin Cold Caps
  4. Chemotherapy Cold Caps
  5. Medline Industries

Global Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Overview


Highlights of The Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Scalp Cool Caps
    2. Scalp Cool Systems
  1. By Application:

    1. Breast Cancer
    2. Prostate Cancer
    3. Ovarian Cancer
    4. Ovarian Cancer
    5. Lung Cancer
    6. Other Solid Tumors
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Scalp Cool Devices for Chemotherapy Induced Hair Loss Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Scalp Cool Devices for Chemotherapy Induced Hair Loss is a device that is used to cool the scalp during chemotherapy treatments. This can help to reduce hair loss and improve your scalp's health.

Some of the key players operating in the scalp cool devices for chemotherapy induced hair loss market are Dignitana, Paxman, Penguin Cold Caps, Chemotherapy Cold Caps, Medline Industries.

The scalp cool devices for chemotherapy induced hair loss market is expected to register a CAGR of 5.3%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Scalp Cool Devices for Chemotherapy Induced Hair Loss Market - Supply Chain
   4.5. Global Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Forecast
      4.5.1. Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Absolute $ Opportunity

5. Global Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Type
      5.3.1. Scalp Cool Caps
      5.3.2. Scalp Cool Systems
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Application
      6.3.1. Breast Cancer
      6.3.2. Prostate Cancer
      6.3.3. Ovarian Cancer
      6.3.4. Ovarian Cancer
      6.3.5. Lung Cancer
      6.3.6. Other Solid Tumors
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Scalp Cool Devices for Chemotherapy Induced Hair Loss Demand Share Forecast, 2019-2026

9. North America Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Application
      9.4.1. Breast Cancer
      9.4.2. Prostate Cancer
      9.4.3. Ovarian Cancer
      9.4.4. Ovarian Cancer
      9.4.5. Lung Cancer
      9.4.6. Other Solid Tumors
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Type
      9.7.1. Scalp Cool Caps
      9.7.2. Scalp Cool Systems
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Scalp Cool Devices for Chemotherapy Induced Hair Loss Demand Share Forecast, 2019-2026

10. Latin America Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Application
      10.4.1. Breast Cancer
      10.4.2. Prostate Cancer
      10.4.3. Ovarian Cancer
      10.4.4. Ovarian Cancer
      10.4.5. Lung Cancer
      10.4.6. Other Solid Tumors
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Type
      10.7.1. Scalp Cool Caps
      10.7.2. Scalp Cool Systems
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Scalp Cool Devices for Chemotherapy Induced Hair Loss Demand Share Forecast, 2019-2026

11. Europe Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Application
      11.4.1. Breast Cancer
      11.4.2. Prostate Cancer
      11.4.3. Ovarian Cancer
      11.4.4. Ovarian Cancer
      11.4.5. Lung Cancer
      11.4.6. Other Solid Tumors
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Type
      11.7.1. Scalp Cool Caps
      11.7.2. Scalp Cool Systems
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Scalp Cool Devices for Chemotherapy Induced Hair Loss Demand Share, 2019-2026

12. Asia Pacific Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Application
      12.4.1. Breast Cancer
      12.4.2. Prostate Cancer
      12.4.3. Ovarian Cancer
      12.4.4. Ovarian Cancer
      12.4.5. Lung Cancer
      12.4.6. Other Solid Tumors
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Type
      12.7.1. Scalp Cool Caps
      12.7.2. Scalp Cool Systems
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Scalp Cool Devices for Chemotherapy Induced Hair Loss Demand Share, 2019-2026

13. Middle East & Africa Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Application
      13.4.1. Breast Cancer
      13.4.2. Prostate Cancer
      13.4.3. Ovarian Cancer
      13.4.4. Ovarian Cancer
      13.4.5. Lung Cancer
      13.4.6. Other Solid Tumors
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Size and Volume Forecast by Type
      13.7.1. Scalp Cool Caps
      13.7.2. Scalp Cool Systems
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Scalp Cool Devices for Chemotherapy Induced Hair Loss Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Scalp Cool Devices for Chemotherapy Induced Hair Loss Market: Market Share Analysis
   14.2. Scalp Cool Devices for Chemotherapy Induced Hair Loss Distributors and Customers
   14.3. Scalp Cool Devices for Chemotherapy Induced Hair Loss Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Dignitana
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Paxman
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Penguin Cold Caps
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Chemotherapy Cold Caps
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Medline Industries
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. COMPANY6
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. COMPANY7
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. COMPANY8
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
  &nb

Our Trusted Clients

Contact Us